Yahoo Finance published an article about Code Pharma: “The company today announced its intention to launch an Initial Public Offering (IPO) and list its shares on the NASDAQ and Switzerland’s SIX Swiss Exchange”.
Zyon Ayni, CEO and Founder of Code Pharma, quoted: “Today is a very exciting day for the Code Pharma team. We are well-positioned to play a key role in the current race to develop a cure for COVID-19. Our drug Codivir – which was originally discovered at the Hebrew University in Israel – has a very good safety profile and very impressive antiviral activity, both under laboratory conditions and in our phase I clinical trials”.